Temporal Nrf2-mTOR Dual Switch Therapy
🧪 Overview
Sequential activation of Nrf2 followed by mTOR modulation can orchestrate beneficial astrocyte substate transitions. Initial Nrf2 activation counteracts NF-κB inflammatory cascades, while subsequent mTOR pathway modulation maintains neuroprotective substates and prevents reversion to neurotoxic phenotypes.
Debate provenance: derived from debate `sess_SDA-2026-04-10-sda-2026-04-01-gap-007` on question: Astrocyte reactivity subtypes in neurodegeneration. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms NFE2L2/MTOR, Nrf2-mTOR, Switch, Temporal, activation, astrocyte, modulation. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
BMAL1["BMAL1"] -->|associated with| neurodegeneration["neurodegeneration"]
HK2["HK2"] -->|associated with| neurodegeneration_1["neurodegeneration"]
P2RY1["P2RY1"] -->|interacts with| P2RX7["P2RX7"]
P2RY1_2["P2RY1"] -->|associated with| neurodegeneration_3["neurodegeneration"]
P2RX7_4["P2RX7"] -->|associated with| neurodegeneration_5["neurodegeneration"]
P2RX7_6["P2RX7"] -->|interacts with| P2RY1_7["P2RY1"]
MIRO1["MIRO1"] -->|associated with| neurodegeneration_8["neurodegeneration"]
PIEZO1["PIEZO1"] -->|interacts with| KCNK2["KCNK2"]
KCNK2_9["KCNK2"] -->|interacts with| PIEZO1_10["PIEZO1"]
P2RY1_11["P2RY1"] -->|participates in| Purinergic_signaling["Purinergic signaling"]
P2RX7_12["P2RX7"] -->|participates in| Purinergic_signaling_13["Purinergic signaling"]
DGAT1["DGAT1"] -->|interacts with| SOAT1["SOAT1"]
style BMAL1 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style HK2 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_1 fill:#ef5350,stroke:#333,color:#000
style P2RY1 fill:#ce93d8,stroke:#333,color:#000
style P2RX7 fill:#ce93d8,stroke:#333,color:#000
style P2RY1_2 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_3 fill:#ef5350,stroke:#333,color:#000
style P2RX7_4 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_5 fill:#ef5350,stroke:#333,color:#000
style P2RX7_6 fill:#ce93d8,stroke:#333,color:#000
style P2RY1_7 fill:#ce93d8,stroke:#333,color:#000
style MIRO1 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_8 fill:#ef5350,stroke:#333,color:#000
style PIEZO1 fill:#ce93d8,stroke:#333,color:#000
style KCNK2 fill:#ce93d8,stroke:#333,color:#000
style KCNK2_9 fill:#ce93d8,stroke:#333,color:#000
style PIEZO1_10 fill:#ce93d8,stroke:#333,color:#000
style P2RY1_11 fill:#ce93d8,stroke:#333,color:#000
style Purinergic_signaling fill:#81c784,stroke:#333,color:#000
style P2RX7_12 fill:#ce93d8,stroke:#333,color:#000
style Purinergic_signaling_13 fill:#81c784,stroke:#333,color:#000
style DGAT1 fill:#ce93d8,stroke:#333,color:#000
style SOAT1 fill:#ce93d8,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NFE2L2
No curated PDB or AlphaFold mapping for NFE2L2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NFE2L2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |